A systematic review of the association of diabetic retinopathy and cognitive impairment in people with Type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 96, Issue 2, 2012, Pages 101-110

  Crosby Nwaobi, R ^a   Sivaprasad, S ^b   Forbes, A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cognition; Cognitive impairment; Dementia; Diabetes; Diabetic retinopathy

Indexed keywords

COGNITIVE DEFECT; DATA EXTRACTION; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; LEARNING; MEMORY; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

COGNITION DISORDERS; DEMENTIA; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HUMANS;

EID: 84860504124     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.11.010     Document Type: Review

References (53)

1. International Diabetes Federation. Diabetes facts; 2011. http://www.idf.org/.
2. Royal College of Opthalmologists. Diabetic retinopathy guidelines, 2005. http://www.rcophth.ac.uk/docs/publications/published-guidelines/DiabeticRetinopathyGuidelines2005.pdf.
3. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997, 20:438-445.
4. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 2005, 48:2460-2469.
5. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
6. Mariani E., Monastero R., Mecocci P. Mild cognitive impairment: a systematic review. J Alzheimers Dis 2007, 12:23-35.
7. Strachan M.W., Price J.F., Frier B.M. Diabetes, cognitive impairment, and dementia. BMJ 2008, 336:6.
8. Strachan M.W., Reynolds R.M., Frier B.M., Mitchell R.J., Price J.F. The role of metabolic derangements and glucocorticoid excess in the aetiology of cognitive impairment in type 2 diabetes. Implications for future therapeutic strategies. Diabetes Obes Metab 2009, 11:407-414.
9. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194.
10. Chertkow H., Massoud F., Nasreddine Z., Belleville S., Joanette Y., Bocti C., et al. Diagnosis and treatment of dementia. 3. Mild cognitive impairment and cognitive impairment without dementia. CMAJ 2008, 178:1273-1285.
11. Rait G., Fletcher A., Smeeth L., Brayne C., Stirling S., Nunes M., et al. Prevalence of cognitive impairment: results from the MRC trial of assessment and management of older people in the community. Age Ageing 2005, 34:242-248.
12. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
13. Alzheimer's Society Dementia UK: the full report 2007, London School of Economics and the Institute of Psychiatry at King's College London. http://alzheimers.org.uk/site/scripts/download_info.php%3FfileID=2.
14. Biessels G.J. Cerebral complications of diabetes: clinical findings and pathogenetic mechanisms. Neth J Med 1999, 54:35-45.
15. Luchsinger J.A., Reitz C., Patel B., Tang M.X., Manly J.J., Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007, 64:570-575.
16. Elias P.K., Elias M.F., D'Agostino R.B., Cupples L.A., Wilson P.W., Silbershatz H., et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 1997, 20:1388-1395.
17. Strachan M.W., Frier B.M., Deary I.J. Type 2 diabetes and cognitive impairment. Diabet Med 2003, 20:1-2.
18. Knopman D., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56:42-48.
19. Hassing L.B., Hofer S.M., Nilsson S.E., Berg S., Pedersen N.L., McClearn G., et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004, 33:355-361.
20. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 1997, 145:301-308.
21. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002, 51:1256-1262.
22. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999, 53:1937-1942.
23. Yoshitake T.M., Kiyohara Y.M., Kato I.M., Ohmura T.M., Iwamoto H.M., Nakayama K.M., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study [Article]. Neurology 1995, 45:1161-1168.
24. Hassing L.B., Grant M.D., Hofer S.M., Pedersen N.L., Nilsson S.E., Berg S., et al. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. J Int Neuropsychol Soc 2004, 10:599-607.
25. Xu W., Qiu C., Gatz M., Pedersen N.L., Johansson B., Fratiglioni L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 2009, 58:71-77.
26. Patton N., Aslam T., Macgillivray T., Pattie A., Deary I.J., Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005, 206:319-348.
27. Ding J., Patton N., Deary I.J., Strachan M.W., Fowkes F.G., Mitchell R.J., et al. Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. Br J Ophthalmol 2008, 92:1017-1025.
28. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007, 370:1453-1457.
29. Cullen B., O'Neill B., Evans J.J., Coen R.F., Lawlor B.A. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry 2007, 78:790-799.
30. World Health Organisation International Statistical Classification of Diseases and Related Health Problems 10 2010, World Health Organisation, Geneva, [chapter V]. http://apps.who.int/classifications/icd10/browse/2010/en.
31. Ding J., Strachan M.W., Reynolds R.M., Frier B.M., Deary I.J., Fowkes F.G., et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010, 59:2883-2889.
32. Wong T.Y., Klein R., Sharrett A.R., Nieto F.J., Boland L.L., Couper D.J., et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the atherosclerosis risk in communities study. Stroke 2002, 33:1487-1492.
33. Kadoi Y., Saito S., Fujita N., Goto F. Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg 2005, 129:576-583.
34. Lesage S.R., Mosley T.H., Wong T.Y., Szklo M., Knopman D., Catellier D.J., et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 2009, 73:862-868.
35. Liew G., Mitchell P., Wong T.Y., Lindley R.I., Cheung N., Kaushik S., et al. Retinal microvascular signs and cognitive impairment. J Am Geriatr Soc 2009, 57:1892-1896.
36. Patton N., Pattie A., MacGillivray T., Aslam T., Dhillon B., Gow A., et al. The association between retinal vascular network geometry and cognitive ability in an elderly population. Invest Ophthalmol Vis Sci 2007, 48:1995-2000.
37. Baker M.L., Marino Larsen E.K., Kuller L.H., Klein R., Klein B.E., Siscovick D.S., et al. Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study. Stroke 2007, 38:2041-2047.
38. Petersen R.C., Roberts R.O., Knopman D.S., Geda Y.E., Cha R.H., Pankratz V.S., et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology 2010, 75:889-897.
39. Komulainen P, Lakka TA, Hassinen M, Hanninen HT, Kouki R, Kivipelto M, Rauramaa R. Glucose tolerance and cognitive function in men and women: DR'S extra study (ISRCTN45977199). In: Sciences EJotN (ed), 5th International Congress on Vascular Dementia. Budapest Hungary; 2009:283 (1-2) (pp. 288).
40. Bruce D.G., Davis W.A., Casey G.P., Starkstein S.E., Clarnette R.M., Foster J.K., et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008, 51:241-248.
41. Royall D.R., Lauterbach E.C., Cummings J.L., Reeve A., Rummans T.A., Kaufer D.I., et al. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002, 14:377-405.
42. Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
43. Reding M., Haycox J., Blass J. Depression in patients referred to a dementia clinic. A three-year prospective study. Arch Neurol 1985, 42:894-896.
44. Visser P.J., Verhey F.R., Ponds R.W., Kester A., Jolles J. Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc 2000, 48:479-484.
45. Swainson R., Hodges J.R., Galton C.J., Semple J., Michael A., Dunn B.D., et al. Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 2001, 12:265-280.
46. Modrego P.J., Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004, 61:1290-1293.
47. Ganguli M., Du Y., Dodge H.H., Ratcliff G.G., Chang C.C. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry 2006, 63:153-160.
48. Stewart R., Richards M., Brayne C., Mann A. Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J Am Geriatr Soc 2001, 49:263-269.
49. ETDRS Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991, 98:823-833.
50. Klein R., Klein B.E., Magli Y.L., Brothers R.J., Meuer S.M., Moss S.E., et al. An alternative method of grading diabetic retinopathy. Ophthalmology 1986, 93:1183-1187.
51. Klein R., Klein B.E., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1989, 107:237-243.
52. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995, 45:1161-1168.
53. Biessels G.J., Kerssen A., de Haan E.H., Kappelle L.J. Cognitive dysfunction and diabetes: implications for primary care. Prim Care Diabetes 2007, 1:187-193.